EyePoint
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell EyePoint and other ETFs, options, and stocks.About EYPT
EyePoint Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands.
CEOJay S. Duker
CEOJay S. Duker
Employees165
Employees165
HeadquartersWatertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded1987
Founded1987
Employees165
Employees165
EYPT Key Statistics
Market cap1.55B
Market cap1.55B
Price-Earnings ratio-5.83
Price-Earnings ratio-5.83
Dividend yield—
Dividend yield—
Average volume1.59M
Average volume1.59M
High today$18.96
High today$18.96
Low today$17.34
Low today$17.34
Open price$17.36
Open price$17.36
Volume713.70K
Volume713.70K
52 Week high$19.11
52 Week high$19.11
52 Week low$3.91
52 Week low$3.91
Stock Snapshot
With a market cap of 1.55B, EyePoint(EYPT) trades at $18.74. The stock has a price-to-earnings ratio of -5.83.
On 2025-12-22, EyePoint(EYPT) stock traded between a low of $17.34 and a high of $18.96. Shares are currently priced at $18.74, which is +8.1% above the low and -1.2% below the high.
The EyePoint(EYPT)'s current trading volume is 713.7K, compared to an average daily volume of 1.59M.
During the past year, EyePoint(EYPT) stock moved between $3.91 at its lowest and $19.11 at its peak.
During the past year, EyePoint(EYPT) stock moved between $3.91 at its lowest and $19.11 at its peak.
Analyst ratings
100%
of 12 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own EYPT. This list is generated using Robinhood data, and it’s not a recommendation.